Bio-Rad Laboratories, Inc. (BIO)
NYSE: BIO · Real-Time Price · USD
243.00
-4.16 (-1.68%)
Mar 28, 2025, 4:00 PM EDT - Market closed

Bio-Rad Laboratories Statistics

Total Valuation

BIO has a market cap or net worth of $7.68 billion. The enterprise value is $7.39 billion.

Market Cap 7.68B
Enterprise Value 7.39B

Important Dates

The next estimated earnings date is Tuesday, May 6, 2025, after market close.

Earnings Date May 6, 2025
Ex-Dividend Date n/a

Share Statistics

BIO has 31.62 million shares outstanding. The number of shares has decreased by -3.41% in one year.

Current Share Class 26.55M
Shares Outstanding 31.62M
Shares Change (YoY) -3.41%
Shares Change (QoQ) +0.04%
Owned by Insiders (%) 14.19%
Owned by Institutions (%) 60.34%
Float 23.05M

Valuation Ratios

PE Ratio n/a
Forward PE 25.38
PS Ratio 2.67
Forward PS 2.97
PB Ratio 1.04
P/TBV Ratio 1.31
P/FCF Ratio 26.53
P/OCF Ratio 16.88
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 17.58, with an EV/FCF ratio of 25.53.

EV / Earnings n/a
EV / Sales 2.88
EV / EBITDA 17.58
EV / EBIT 27.49
EV / FCF 25.53

Financial Position

The company has a current ratio of 6.48, with a Debt / Equity ratio of 0.21.

Current Ratio 6.48
Quick Ratio 4.55
Debt / Equity 0.21
Debt / EBITDA 2.80
Debt / FCF 4.75
Interest Coverage 5.50

Financial Efficiency

Return on equity (ROE) is -24.09% and return on invested capital (ROIC) is 1.86%.

Return on Equity (ROE) -24.09%
Return on Assets (ROA) 1.55%
Return on Invested Capital (ROIC) 1.86%
Return on Capital Employed (ROCE) 3.02%
Revenue Per Employee $333,312
Profits Per Employee -$239,506
Employee Count 7,700
Asset Turnover 0.24
Inventory Turnover 1.54

Taxes

Income Tax -498.30M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -30.48% in the last 52 weeks. The beta is 0.99, so BIO's price volatility has been similar to the market average.

Beta (5Y) 0.99
52-Week Price Change -30.48%
50-Day Moving Average 294.80
200-Day Moving Average 317.66
Relative Strength Index (RSI) 31.80
Average Volume (20 Days) 404,254

Short Selling Information

The latest short interest is 1.00 million, so 3.17% of the outstanding shares have been sold short.

Short Interest 1.00M
Short Previous Month 609,993
Short % of Shares Out 3.17%
Short % of Float 4.35%
Short Ratio (days to cover) 2.59

Income Statement

In the last 12 months, BIO had revenue of $2.57 billion and -$1.84 billion in losses. Loss per share was -$65.36.

Revenue 2.57B
Gross Profit 1.38B
Operating Income 269.00M
Pretax Income -1.73B
Net Income -1.84B
EBITDA 420.60M
EBIT 269.00M
Loss Per Share -$65.36
Full Income Statement

Balance Sheet

The company has $1.66 billion in cash and $1.37 billion in debt, giving a net cash position of $289.80 million or $9.16 per share.

Cash & Cash Equivalents 1.66B
Total Debt 1.37B
Net Cash 289.80M
Net Cash Per Share $9.16
Equity (Book Value) 6.57B
Book Value Per Share 234.52
Working Capital 2.56B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $455.20 million and capital expenditures -$165.60 million, giving a free cash flow of $289.60 million.

Operating Cash Flow 455.20M
Capital Expenditures -165.60M
Free Cash Flow 289.60M
FCF Per Share $9.16
Full Cash Flow Statement

Margins

Gross margin is 53.73%, with operating and profit margins of 10.48% and -71.86%.

Gross Margin 53.73%
Operating Margin 10.48%
Pretax Margin -91.27%
Profit Margin -71.86%
EBITDA Margin 16.39%
EBIT Margin 10.48%
FCF Margin 11.28%

Dividends & Yields

BIO does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield 3.41%
Shareholder Yield n/a
Earnings Yield -24.00%
FCF Yield 3.77%
Dividend Details

Analyst Forecast

The average price target for BIO is $415.25, which is 70.89% higher than the current price. The consensus rating is "Strong Buy".

Price Target $415.25
Price Target Difference 70.89%
Analyst Consensus Strong Buy
Analyst Count 4
Revenue Growth Forecast (5Y) 3.68%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on March 8, 2002. It was a forward split with a ratio of 2:1.

Last Split Date Mar 8, 2002
Split Type Forward
Split Ratio 2:1

Scores

BIO has an Altman Z-Score of 3.75 and a Piotroski F-Score of 6.

Altman Z-Score 3.75
Piotroski F-Score 6